Hypoxia and inflammation [5]

New England Journal of Medicine

Volumn 364, Issue 20, 2011, Pages 1976-1977

  Wilcox, Ian ^a   Chan, Kim Hoe ^a   Lattimore, Jo Dee ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ARTERY DISEASE; ATHEROSCLEROSIS; DYSLIPIDEMIA; HUMAN; HYPERTENSION; HYPOXIA; INFLAMMATION; INSULIN RESISTANCE; LETTER; PRIORITY JOURNAL; REOXYGENATION; SLEEP APNEA SYNDROME; VASCULAR DISEASE; ANOXIA; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY; REPERFUSION INJURY;

ANOXIA; ATHEROSCLEROSIS; HUMANS; INFLAMMATION; SLEEP APNEA, OBSTRUCTIVE; CARRIER PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1; INFLAMMASOMES; REPERFUSION INJURY;

CARRIER PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; INFLAMMASOME; NLRP3 PROTEIN, HUMAN;

EID: 79956194017     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1103019     Document Type: Letter

References (4)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26. (Pubitemid 29054847)
2. Dean RT, Wilcox I. Possible atherogenic effects of hypoxia during obstructive sleep apnea. Sleep 1993;16:Suppl:S15-S21.
3. Lattimore J-D, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 2003;41:1429-37. (Pubitemid 36543356)
4. Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE. "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax 1998;53:Suppl 3:S25-S28.